Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials – The New York Times

Last year, Medicares actuarial division, acting without knowing what the coverage decision would be, imposed one of the biggest-ever increases in Medicare Part B premiums for 2022, partly driven by t… [+1357 chars]